How to buy, sell and short Pfizer shares
Pfizer is one of the world’s largest pharmaceutical companies, with a focus on developing medicines, vaccines and consumer healthcare products. Discover how you can buy and sell Pfizer shares with IG.
How to buy or invest in Pfizer shares
There are two key ways of getting exposure to a company’s share price: investing and trading. Investing involves buying physical stock in the company in the hope the price will increase, while trading means speculating on its share price movements without taking ownership.
Follow the steps below to trade on Pfizer shares:
Instead of investing, you can choose to trade on the Pfizer share price with CFDs. These products offer the following benefits:
- Get full exposure with a small deposit – usually just 20% of the full value of the trade1
- Enjoy extended hours on Pfizer shares so you can trade when announcements happen: 9am to 1am (UK time)
How to sell or short Pfizer shares
It’s possible to sell physical Pfizer shares through IG, even if you bought them through another provider. You can do this by transferring them to us for free.
You can also back Pfizer’s share price to fall by shorting or going short. Consider shorting Pfizer shares via CFDs if you:
- Want to speculate on Pfizer’s share price. If you believe the value of Pfizer shares will go down, you’d put in a ‘sell’ order
- Already hold a ‘buy’ position or own shares in the company, but you want to hedge the portfolio with a ‘sell’ position in order to reduce risk. This is like having a backup if the market turns from bullish to bearish
Here’s how to sell or short Pfizer shares with us:
Pfizer’s live market price
Pfizer is listed on the New York Stock Exchange (NYSE) under the ticker PFE.
Pfizer shares: the basics
Pfizer is based in New York, however it has offices and subsidiaries all over the world – including multiple spinoff companies. That means you can speculate on the Pfizer share price directly, or on a variety of related companies.
New drugs are often the cause for spikes in value. For example, the Pfizer share price peaked in 1999 at $50.03, partly due to the launch of Viagra the previous year. And following the release of its Covid-19 vaccine in 2020, Pfizer shares reached an annual high of $42.56 in December that year.
Just over 27% of the company’s shares are owned by members of the public. The other 73% are owned by institutions. Large institutions don’t often back companies with a poor track record, so the shareholder weighting is often considered to add credibility to the stock.
What is Pfizer’s business model?
Pfizer’s business model is based on the research, production and sale of pharmaceutical drugs. These include prescription drugs and over-the-counter products. Pfizer also develops oncology solutions and healthcare products used in hospitals and treatment centres.
Pfizer has joint interests in third-party and spinoff companies. As well as a joint venture with GlaxoSmithKline, it has two subsidiaries focusing on agriculture and animals. The Agriculture Division of Pfizer and Pfizer Animal Health come under the umbrella of Zoetis.
Pfizer key personnel: who manages the company?
Albert Bourla | Chairman and chief executive officer |
John Young | Group president and chief business officer |
Frank D'Amelio | Chief financial officer and executive VP of global supply |
Mikael Dolsten | Chief scientific officer and president of worldwide research, development and medical |
Sally Susman | Executive vice president, chief corporate affairs officer |
Angela Hwang | Group president, Pfizer Biopharmaceuticals Group |
Charles Triano | Senior vice president of investor relations |
Douglas Lankler | Executive vice president and general counsel |
Rady Johnson | Executive vice president and chief compliance, quality and risk officer |
Rod MacKenzie | Chief development officer and executive vice president of global product development |
Payal Sahni | Executive vice president, chief human resources officer |
Lidia Fonseca | Chief digital and technology officer, executive vice president |
Pfizer share price: how to analyse Pfizer shares
Analysing Pfizer shares requires a combination of both technical analysis and fundamental analysis:
- Technical analysis: This looks at price charts, technical indicators and other statistical metrics to get a sense of where a company’s share price might go next. Technical analysis also allows you to compare points of significance in an effort to identify potential patterns
- Fundamental analysis: This looks at the fundamentals of a company, including key releases such as revenue reports, dividends and any significant changes to its business model. This type of information is available through Pfizer’s quarterly updates, and you can read the latest news via our market data page
Buying and selling Pfizer shares summed up
- You don’t have to invest in Pfizer shares to profit from their price movements. You can use CFDs to speculate on those movements instead
- Going short via CFDs enables you to make a profit if the company’s value decreases, or to hedge against existing investments
- You can transfer your existing electronic shares to us for free
- Our technical and fundamental analysis can help you get a better understanding of the Pfizer share price
Footnotes:
1 Deposits on leveraged trades are 20%-25% for 99.14% of tier-one shares (correct as of 1 June 2020). For more information, view our share trading margin rates.
IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.
The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.
Please see important Research Disclaimer.
Explore the markets with our free course
Discover and learn how the range of markets you can trade on with IG Academy's online course – ‘Introducing the financial markets’.
Put learning into action
Try out what you’ve learned in this shares strategy article risk-free in your demo account.
Ready to trade shares?
Put the lessons in this article to use in a live account – upgrading is quick and easy.
- Trade on over 10,000 popular global stocks
- Protect your capital with risk management tools
- React to breaking news with out-of-hours trading on 70 key US stocks
Inspired to trade?
Put your new knowledge into practice. Log in to your account now.